Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.040
-0.050 (-2.39%)
At close: Apr 22, 2026, 4:00 PM EDT
2.010
-0.030 (-1.47%)
Pre-market: Apr 23, 2026, 8:21 AM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $86.17 million as of April 23, 2026. Its market cap has increased by 87.95% in one year.
Market Cap
86.17M
Enterprise Value
66.07M
1-Year Change
87.95%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $86.17M, a decrease of -30.86%. That is a compound annual growth rate of -6.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 88.29M | -28.71% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 93.20M |
| Fractyl Health | 91.30M |
| eXoZymes | 90.39M |
| PolyPid | 89.50M |
| LeonaBio | 88.11M |
| TScan Therapeutics | 85.94M |
| Seres Therapeutics | 85.70M |
| MAIA Biotechnology | 85.55M |